Johannes Fischer’s Post

Growth and Innovation: Intuitive's Q1 2024 Earnings Highlights The remarkable achievements of Intuitive in the first quarter of 2024, marking a period of sustained growth and groundbreaking advancements. 📈 Growth Highlights: > 16% increase in worldwide da Vinci procedures compared to Q1 2023. > 313 da Vinci surgical systems placed, maintaining a steady pace with last year's installations. > Installed base of da Vinci systems grew by 14% to 8,887. > Q1 Revenue soared to $1.89 billion, an 11% increase from $1.70 billion in Q1 2023. 💡 Innovative Breakthroughs: > Received CE mark for the #daVinciSP system and placed 8 units in Europe. > FDA clearance obtained for #daVinci5, the next-gen robotic system. > NMPA regulatory clearance in China for the Ion endoluminal system. 📊 Financial Performance: >GAAP net income jumped to $545 million, a rise from $355 million in Q1 2023. > Non-GAAP net income stood at $541 million, up from $437 million last year. 🌐 CEO Gary Guthart comments, "The core measures of our business remained healthy this quarter as we reached meaningful milestones across several parts of our business. We are pleased by feedback from our measured da Vinci 5 launch as well as the continued adoption of SP and Ion, and we remain focused on delivering the goals we share with our customers, including improving patient outcomes." Here’s to a future where technology and care converge to deliver better patient outcomes. #Intuitive #EarningsUpdate #HealthcareInnovation #RoboticSurgery #MedicalTechnology #daVinciSurgery #CorporateGrowth https://lnkd.in/ehuFb-8w

Consolidating Medical Devices sector with acquisition brings innovations and momentum forward.

Operating Room Integration Market worth $3.7 billion by 2028 Download PDF Brochure: https://lnkd.in/gUMKBSat The global operating room integration market in terms of revenue was estimated to be worth $2.1 billion in 2023 and is poised to reach $3.7 billion by 2028, growing at a CAGR of 12.1% from 2023 to 2028. Top companies working in market Stryker KARL STORZ Olympus Corporation Getinge STERIS Koninklijke Kentalis Hill Rom Holdings Netherlands B.V., Smith+Nephew Medtronic Drägerwerk AG & Co. KGaA Siemens Healthineers GE HealthCare Skytron EIZO Healthcare Barco Canon Medical Systems Corporation Sony Brainlab Arthrex. Richard Wolf GmbH TRUMPF Medical Systems Merivaara Corp. NDS Surgical Imaging Becton, Dickinson and Company CONMED Corporation Karl Kaps Leica Microsystems Novanta Inc. Smiths Medical Zimmer Biomet #operatingroomintegration #surgicalinnovation #orintegration #healthcaretechnology #surgicalsuite #medtech #surgicalefficiency #healthcareit #smartsurgery #digitalor

📈 TINAVI Announces 2023 Interim Report On August 22, 2023, TINAVI Medical Technologies Co., Ltd. (Stock Code: 688277) released its 2023 Interim Report, providing a comprehensive overview of the company's financial performance and operational achievements during the first half of the year. 💰 Financial Highlights: • Operating revenue for the first half of 2023 reached approximately 820 million yuan, marking a robust year-on-year growth of 34.41%. • Net loss attributable to shareholders of the listed company amounted to approximately -370 million yuan, demonstrating a noteworthy reduction of 16.48% compared to the same period last year. 💡 Clinical Reach and Expansion: • By the end of the first quarter of 2023, the clinical application of TiRobot® orthopedic robots had expanded to encompass more than 170 medical institutions across 30 provinces, autonomous regions, and municipalities. • The surgical volume conducted using TiRobot® orthopedic robots surpassed 40,000 cases. #medicaldevices #medicalrobotics #surgicalrobotics #clinicaldevelopment #financialgrowth

💪 Inovedis GmbH, a medical technology start-up dedicated to offering innovative solutions that contribute to optimized patient care and minimizing the complexity of surgical interventions, announced the successful close of a Series A funding round totaling $4 million.   🤝 This funding round was supported by all of Inovedis’s initial seed round investors including HTGF | High-Tech Gründerfonds, MBG Mittelständische Beteiligungsgesellschaft Baden-Württemberg GmbH, Volksbank Albstadt eG ChancenKapital, Start-up BW Innovation Fonds and angel investors, as well as by an initial investment by RENOLIT SE, the current manufacturer of the SINEFIX implant. 💸 Inovedis will use the recent funding to support the commercial launch of the SINEFIX® implant system in the United States where there are over 1 million rotator cuff surgeries each year. The funding will also go towards sponsoring a clinical study taking place in Germany to generate data needed in support of CE marking and expansion of sales into Europe.  Learn more by following the link in the comments 👇

The global 𝐒𝐮𝐫𝐠𝐢𝐜𝐚𝐥 𝐑𝐨𝐛𝐨𝐭𝐬 market in terms of revenue was estimated to be worth $8.5 billion in 2022 and is poised to reach $18.4 billion by 2027, growing at a CAGR of 16.6% from 2022 to 2027. 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐭𝐡𝐞 𝐅𝐑𝐄𝐄 𝐏𝐃𝐅 𝐒𝐚𝐦𝐩𝐥𝐞 𝐚𝐭 https://lnkd.in/dhpssQWu North America will account for the largest share of the market. The region's large share can be attributed to the surge in the adoption of surgical robots by hospitals in the country, the increasing volume of robotic-assisted surgical procedures, and the favourable reimbursement policies. 𝐓𝐨𝐩 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬: Intuitive Surgical Devices Stryker Medtronic Smith & Nephew, Inc. Zimmer Biomet Asensus Surgical Siemens Healthineers Renishaw CMR Surgical CMR Surgical Brasil THINK Surgical Corin Group PRECEYES B.V. Microsure Titan Medical Inc. avateramedical Digital Solutions GmbH Medicaroid Medicaroid Europe GmbH Medicaroid Asia Pacific Brainlab eCential Robotics Globus Medical Johnson & Johnson Momentis Surgical™ SUDHIR SRIVASTAVA MEDICAL INNOVATIONS PRIVATE LIMITED TINAVI Medical Technologies Co., Ltd Distalmotion Monteris Medical #SurgicalRobots #SurgicalRobotsMarket

🚀 Exciting Times in the Surgical Power Tools Market! 🚀 The surgical power tools market has seen remarkable growth, and we're expecting even more expansion in the coming years. Let's explore the driving factors and emerging trends shaping this dynamic industry. Key Growth Drivers: ✅ Surgeon training initiatives ✅ Regional adoption dynamics ✅ Foundational regulatory standards Future Expansion Highlights: ✅ Integration of digital and robotic features ✅ Market penetration strategies ✅ Enhanced surgeon training programs ✅ Healthcare infrastructure expansion Emerging Trends: 🔍 Emphasis on safety and precision 🔍 Demand for specialized surgical techniques 🔍 Increased adoption of robotics A major driving force is the rise in knee and hip replacement surgeries, which rely heavily on surgical power tools for precision and efficacy. Leading Market Players: 🔸 Johnson & Johnson 🔸 3M 🔸 Medtronic PLC 🔸 Stryker Corporation 🔸 Zimmer Biomet Holdings Inc. 🔸 Olympus Corporation Innovative advancements like Stryker Corporation’s CD NXT System are transforming surgical precision with real-time depth measurement systems. Strategic moves, such as Globus Medical Inc.'s acquisition of Capstone Surgical Technologies, further propel market growth. With North America leading the market and Asia-Pacific set for rapid growth, the future of surgical power tools is bright. Stay tuned for more updates on this exciting journey! https://lnkd.in/gm78-_DP #SurgicalPowerTools #HealthcareInnovation #MedicalTechnology #MarketGrowth #SurgicalPrecision

Joe Mullings, the proposed acquisition of Asensus Surgical by KARL STORZ presents an interesting challenge in the surgical robotics market. Key considerations: 1. Integrating technologies, cultures, and operations will be critical for success. Asensus has struggled against Intuitive Surgical. 2. This move could strengthen Karl Storz's position, challenging Intuitive's dominance. But Asensus' regulatory issues must be addressed. 3. Combining Asensus' vision platform with Karl Storz's laparoscopic systems could enable innovative new products and features. Navigating the rapidly evolving surgical tech landscape will be crucial for the combined company. Careful integration and strategic alignment will be key. I'm happy to discuss the potential impact of this deal further. #MedicalTechnology #SurgicalRobotics #M&A #Innovation https://lnkd.in/gJUZBTzr Stryker Intuitive Johnson & Johnson MedTech Moon Surgical Distalmotion ACCREA Engineering #patientswinning Tom Salemi

KARL STORZ and Asensus Surgical acquisition introduces a wild card into the soft tissue, surgical robotic, imaging and navigation market. The acquisition is one thing, threading the needle to "what to do next" may be the bigger challenge. Both teams independently bring value to the table for each other. Getting caught in the tide of boiling the ocean with the potential partnership is going to be where diligence and discipline will need to be exercised. Tom Salemi and I discussed this on the "hot off the press" session of DeviceTalks we had on Friday. We go deep on the discussion of the possible deal Full session in comments. Medtronic, Johnson & Johnson, Intuitive

Ark Surgical Ltd., a pioneering medical device company within the www.intempo.ventures portfolio, has secured $1.1 million to advance safer surgical solutions tailored specifically for Women's Health. Sealed between December 2023 and January 2024, this investment marks a pivotal milestone for Ark Surgical as it pursues its mission to improve women's healthcare with safer surgical interventions. The infusion of funds will predominantly fuel the company's strategic expansion efforts in the United States, particularly in promoting its FDA-cleared tissue containment system, the #LapBox. Entities in this funding round include Intempo Ventures, New Generation Technologies NGT3, the Israel Innovation Authority (IIA), and the Israel Ministry of Economy and Industry. Additionally, Ark Surgical has garnered support from a distinguished U.S.-based medical device group comprising seasoned physicians and executives renowned for their extensive expertise in the healthcare landscape. The #LapBox containment system directly addresses the FDA's imperative to mitigate the risk of undiagnosed cancer dissemination during tissue morcellation, all while enhancing patient outcomes by facilitating minimally invasive alternatives to conventional, higher-risk open surgeries. Learn more in Femtech Insider > https://lnkd.in/dtnpAA7E #womenshealth #gynecology #medtech #healthcareinvestment #medicaldevices